Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sTie-2 | cis | Discovery | rs35030851 | 9:27,197,486 | G/T | 0.05 | 996 | 0.924 | 0.096 | 4.1×10-21 | 1.140 | 1.1×10-21 | 1.1×10-22 |
sTie-2 | cis | Replication | rs45563539 | 9:27,203,002 | G/A | 0.08 | 337 | 0.540 | 0.116 | 4.3×10-6 | 1.110 | 4.8×10-6 | 1.7×10-5 |
Target (abbrv.) | sTie-2 |
Target (full name) | Angiopoietin-1 receptor, soluble |
Somalogic ID (Sequence ID) | SL003200 (3773-15_4) |
Entrez Gene Symbol | TEK |
UniProt ID | Q02763 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs35030851) and 8 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
Genes hit or close-by |
|
Potentially regulated genes |
|
Trait | P | Study | Source |
---|---|---|---|
Schizophrenia | 2.3×10-4 | 23974872 (PMID) | Supplemental file |